| Rheumatoid Arthritis |
1 |
1 |
| Vagus Nerve Stimulation |
0 |
0.99 |
| Nerve |
0 |
0.83 |
| Systemic Lupus Erythematosus |
0 |
0.41 |
| Osteoarthritis |
0 |
0.35 |
| Ear |
0 |
0.98 |
| Otolaryngology |
0 |
0.25 |
| COVID-19 |
0 |
0.19 |
| Headache |
0 |
0.19 |
| Pain Management |
0 |
0.19 |
| Arthritis |
0 |
0.13 |
| Disease-Modifying Antirheumatic Drugs |
0 |
0.13 |
| Biologic Therapy |
0 |
0.11 |
| Healthcare and Medical Technology |
0 |
0.11 |
| Hand Osteoarthritis |
0 |
0.09 |
| Renal Disease |
0 |
0.09 |
| Autoimmune Disease |
0 |
0.06 |
| Child |
0 |
0.06 |
| Clinical Research |
0 |
0.06 |
| Cluster Headaches |
0 |
0.06 |
| Cytokines |
0 |
0.06 |
| Hand |
0 |
0.06 |
| Immunology |
0 |
0.06 |
| Kidney |
0 |
0.06 |
| Lupus |
0 |
0.06 |
| New York |
0 |
0.06 |
| Pain |
0 |
0.06 |
| Post-Acute Sequelae of SARS-CoV-2 Infection |
0 |
0.06 |
| Spleen |
0 |
0.06 |
| Texas |
0 |
0.06 |
| Tinnitus |
0 |
0.06 |
| Tumor |
0 |
0.06 |